Shanghai Huilun Jiangsu Pharmaceutical is a Pharmaceutical company company operating in the pharmaceutical industry.
Shanghai Huilun Pharma is a manufacturer of APIs, intermediates and Finished formulations, with 2 manufacturing sites located in Jiangsu and Hubei provinces. Huilun Pharma is now producing APIs include Ticagrelor, Rivaroxaban, Silodosin, TAF, Sugammadex, Azacitidine, Relugolix, Cabozantinib, Palbociclib, Ibrutinib, etc.
Company type
Pharmaceutical company
Products and services
APIs (Active Pharmaceutical Ingredients)
Markets
East Asia (e.g. China, Japan, Korea), Europe – non EU (e.g. UK, Russia, ex-CIS countries), South Asia (e.g. India, Pakistan, Sri Lanka)
Address
Shanghai Huilun Jiangsu Pharmaceutical, Building 9, No. 18, Yangtze Road, Binjiang Industrial Park, Taizhou, Jiangsu, China, 225300
